ArticlePreventive medicine reports2025
The burden dynamics of leukemia in China from 1990 to 2021: an epidemiological analysis of trends, risk factors, and projections to 2036.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Leukemia disease burden and quality of care among adolescents and young adults in China compared to global patterns: a comprehensive analysis from 1990 to 2021.Frontiers in public health · 2026Article
- Leukemia epidemiology in China: Burden, trends, and determinants in the 21st century.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Leukemia is a key public health challenge in China, with epidemiological patterns shifting due to demographics, environment, and healthcare advances. This study analyzes its trends, risks, and projects future burdens. Methods: Using the Global Burden of Disease Study 2021 database, we evaluated China's leukemia incidence and mortality during 1990-2021. Joinpoint regression identified temporal trends, while age-period-cohort (APC) models dissected age, period, and birth cohort effects. Decomposition analysis quantified contributions of population aging, growth, and epidemiological changes. Bayesian APC models were used to forecast trends into 2036. Risk factors for leukemia-related deaths and disability-adjusted life years (DALYs) were also analyzed. Results: During 1990-2021, leukemia incidence increased by 38.7 %, while mortality declined by 47.1 %. Males exhibited higher mortality and incidence than females. Age-specific trends revealed dual incidence peaks in children (<5 years) and the elderly (>80 years). Decomposition analysis attributed 76.9 % to population expansion. Smoking and high BMI were leading risk factors. The projections to 2036 show the incidence rate for men will rise. Conclusions: Despite therapeutic advances reflected in mortality reductions, escalating incidence among aging populations and occupational hazards necessitate urgent action. Prioritizing sex-specific policies, smoking cessation initiatives, and stricter occupational safety regulations is crucial to curbing future burdens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.